Rider crushed under truck at Thokkottu; ganja found in his two-wheeler

Puttur, Jul 7: A woman died after a wall of compound collapsed on her in Dakshina Kannada district on Tuesday, July 7. 

The victim was identified as Vasanti.

The wall got weakened due to heavy rain at Golithottu area in Puttur. Her body was sent to the post-mortem.

According to the police, the incident took place around 12.30pm when Vasanti was working in the backyard of her house.

Yadgir, Jan 21: A bag was found abandoned at the Yadgir Bus Stand on Tuesday morning that left the commuters in panic.

After receiving the information, a police team, along with a sniffer dog, rushed to the spot. When the bag was checked, the police found clothes and cash in it.

It is stated that a passenger might have left the bag in a hurry to catch the bus.

The United States of America has bought almost the entire world's supply of remdesivir, one of just two drugs proven to treat COVID-19. 

“President Trump has struck an amazing deal to ensure Americans have access to the first authorised therapeutic for Covid-19,” said the US health and human services secretary, Alex Azar. 

“To the extent possible, we want to ensure that any American patient who needs remdesivir can get it. The Trump administration is doing everything in our power to learn more about life-saving therapeutics for Covid-19 and secure access to these options for the American people.”

The announcement implies that no other country in the world will be able to buy remdesivir for next three months at least.

The anti-viral drug patented by the US-based Gilead biotech firm is the only one approved by the European Medicines Agency (EMA) to treat patients with the novel coronavirus.

The Trump administration has already shown that it is prepared to outbid and outmanoeuvre all other countries to secure the medical supplies it needs for the US.

“They’ve got access to most of the drug supply [of remdesivir], so there’s nothing for Europe,” said Dr Andrew Hill, senior visiting research fellow at Liverpool University.

Remdesivir, the first drug approved by licensing authorities in the US to treat Covid-19, is made by Gilead and has been shown to help people recover faster from the disease. 

The first 140,000 doses, supplied to drug trials around the world, have been used up. The Trump administration has now bought more than 500,000 doses, which is all of Gilead’s production for July and 90% of August and September.